import { EducationalContent } from '../../types';

export const genderAffirmingCare: EducationalContent = {
  id: 'gender-affirming-care',
  type: 'concept',
  name: 'Gender-Affirming Care',
  alternateNames: ['Gender Affirmation', 'Transgender Healthcare', 'Gender-Confirming Care'],
  levels: {
    1: {
      level: 1,
      summary: 'Gender-affirming care supports transgender people in living as their true gender, improving mental health and overall wellbeing.',
      explanation: `Gender-affirming care helps transgender people feel comfortable in their bodies and live as their true gender identity. This type of care is medically necessary and saves lives.

**What is Gender-Affirming Care:**
Gender-affirming care supports people whose gender identity is different from the sex they were assigned at birth. It helps align their physical appearance and how society sees them with who they really are.

**Types of Gender-Affirming Care:**

**Social Support:**
- Using the name and pronouns that feel right for the person
- Supporting expression through clothing, hairstyle, and behavior
- Creating safe spaces at home, school, and work
- Connecting with supportive communities

**Mental Health Support:**
- Counseling to explore gender identity
- Support for dealing with discrimination and family challenges
- Treatment for anxiety or depression
- Support through the transition process

**Medical Care:**
- Puberty blockers for young people (delays puberty to give time to explore identity)
- Hormone therapy (estrogen or testosterone to develop desired physical traits)
- Surgeries to change chest, face, or genitals (not everyone wants or needs surgery)

**Why Gender-Affirming Care Matters:**
- Reduces depression and suicide risk
- Improves quality of life
- Helps people feel comfortable in their own bodies
- Supported by all major medical organizations

**Who Provides This Care:**
- Primary care doctors with special training
- Endocrinologists (hormone specialists)
- Mental health professionals
- Surgeons who specialize in gender-affirming procedures

**Common Myths:**
- Gender-affirming care is not "experimental" - it has been provided for decades
- Most care for youth is reversible (like puberty blockers)
- Adults make informed decisions about permanent changes
- This care is supported by medical evidence

Gender-affirming care is recognized as medically necessary by the American Medical Association, American Academy of Pediatrics, and other major health organizations.`,
      keyTerms: [
        { term: 'gender-affirming care', definition: 'Healthcare that supports transgender people in their gender identity' },
        { term: 'transgender', definition: 'A person whose gender identity differs from the sex they were assigned at birth' },
        { term: 'puberty blockers', definition: 'Medications that temporarily pause puberty' },
        { term: 'hormone therapy', definition: 'Treatment with hormones like estrogen or testosterone' },
        { term: 'transition', definition: 'The process of changing to live as one\'s true gender' }
      ],
      analogies: [
        'Gender-affirming care is like giving someone the right-sized shoes - it allows them to walk comfortably through life',
        'Puberty blockers are like hitting the pause button on a video - they give time to make decisions'
      ],
      examples: [
        'A transgender girl takes puberty blockers to prevent facial hair and voice changes',
        'A transgender man takes testosterone to develop a deeper voice and facial hair',
        'A non-binary person uses a new name and pronouns at school with teacher support'
      ]
    },
    2: {
      level: 2,
      summary: 'Gender-affirming care encompasses medical, psychological, and social interventions supporting transgender and gender diverse individuals in living consistent with their gender identity.',
      explanation: `Gender-affirming care refers to evidence-based healthcare supporting transgender and gender diverse individuals in aligning their physical characteristics and social presentation with their gender identity. This care is recognized as medically necessary by major medical organizations.

**Components of Gender-Affirming Care:**

**Social Transition:**
- Name and pronoun changes
- Gender expression through clothing, grooming, and presentation
- Legal documentation changes (name, gender marker)
- Family, school, and workplace support

**Psychological Support:**
- Gender identity exploration and affirmation
- Mental health treatment for co-occurring conditions
- Family therapy to support acceptance
- Coping strategies for minority stress and discrimination

**Medical Interventions:**

**For Adolescents:**
- Pubertal suppression (GnRH agonists) to pause puberty
- Allows time for identity exploration before irreversible changes
- Effects are reversible if stopped
- Initiated at Tanner stage 2-3 of puberty

**Hormone Therapy:**
- Feminizing hormones: estrogen with anti-androgens
- Masculinizing hormones: testosterone
- Gradual physical changes over months to years
- Lifelong treatment for most individuals

**Surgical Interventions:**
- Chest surgery (mastectomy or augmentation)
- Genital surgery (vaginoplasty, phalloplasty, metoidioplasty)
- Facial feminization or masculinization
- Voice surgery (less common)

**Evidence and Outcomes:**

**Mental Health Benefits:**
- Significant reductions in depression and anxiety
- Decreased suicidality (studies show 50-70% reduction in suicide attempts)
- Improved body satisfaction and self-esteem
- Better social functioning and quality of life

**Physical Health Considerations:**
- Hormone therapy requires monitoring for cardiovascular, metabolic, and bone health
- Surgical interventions carry standard surgical risks
- Fertility preservation should be discussed before treatment
- Cancer screening based on organs present

**Guidelines and Standards:**
- World Professional Association for Transgender Health (WPATH) Standards of Care
- Endocrine Society Clinical Practice Guidelines
- American Academy of Pediatrics policy statements
- Require mental health support and informed consent

**Barriers to Access:**
- Insurance exclusions and prior authorization requirements
- Limited number of experienced providers
- Geographic maldistribution of services
- Cost and out-of-pocket expenses
- Legislative restrictions in some jurisdictions

**Patient-Centered Approach:**
Not all transgender people want or need all interventions. Care should be individualized based on:
- Personal goals and priorities
- Medical contraindications
- Fertility desires
- Social support and safety`,
      keyTerms: [
        { term: 'gender identity', definition: 'A person\'s internal sense of being male, female, both, neither, or somewhere in between' },
        { term: 'gender dysphoria', definition: 'Distress experienced when gender identity does not align with assigned sex' },
        { term: 'GnRH agonists', definition: 'Medications that block puberty by stopping sex hormone production' },
        { term: 'feminizing hormones', definition: 'Hormone therapy with estrogen and anti-androgens' },
        { term: 'masculinizing hormones', definition: 'Hormone therapy with testosterone' },
        { term: 'Tanner stage', definition: 'Scale describing physical development during puberty' }
      ],
      analogies: [
        'Gender-affirming care is like correcting a map that had you marked in the wrong location',
        'Hormone therapy is like adjusting the dimmer switch on a light - changes happen gradually over time'
      ],
      examples: [
        'A 14-year-old transgender girl begins puberty blockers to avoid developing facial hair and Adam\'s apple',
        'An adult transgender man undergoes chest masculinization surgery after 2 years on testosterone',
        'A non-binary person takes low-dose testosterone to achieve a more androgynous appearance'
      ]
    },
    3: {
      level: 3,
      summary: 'Gender-affirming care includes evidence-based medical, surgical, and psychosocial interventions for gender dysphoria with established efficacy in improving mental health and quality of life outcomes.',
      explanation: `Gender-affirming care encompasses a range of evidence-based interventions supporting transgender and gender diverse individuals. This care is grounded in decades of clinical experience and research demonstrating significant benefits for patient outcomes.

**Clinical Framework:**

**Assessment and Preparation:**
- Comprehensive biopsychosocial evaluation
- Assessment of gender dysphoria persistence and stability
- Screening for mental health conditions and social support
- Informed consent process including risks, benefits, and alternatives

**Developmental Approaches:**

**Pre-Pubertal Children:**
- Social transition only (name, pronouns, expression)
- No medical interventions
- Supportive mental health care
- Parent education and family therapy

**Adolescents:**
- Pubertal suppression at Tanner stage 2-3 (ages typically 9-14)
- GnRH agonists (leuprolide, histrelin) pause puberty
- Fully reversible intervention allowing time for identity exploration
- Cross-sex hormones typically initiated around age 16 with persistent dysphoria

**Adults:**
- Hormone therapy with informed consent or WPATH assessment
- Dose titration based on desired effects and monitoring
- Surgical options based on individual goals
- Ongoing primary care with attention to hormone-specific risks

**Medical Interventions:**

**Hormone Therapy:**

**Feminizing Regimens:**
- Estrogen (oral, transdermal, or injectable)
- Anti-androgens (spironolactone, bicalutamide, or GnRH agonists)
- Effects: breast development, fat redistribution, decreased muscle mass, reduced body hair, emotional changes
- Timeline: visible changes begin 3-6 months, maximum 2-5 years

**Masculinizing Regimens:**
- Testosterone (injectable, transdermal gel/patch)
- Effects: voice deepening, facial/body hair growth, muscle development, fat redistribution, cessation of menses, clitoral enlargement
- Timeline: voice changes 3-12 months, maximum 5+ years

**Monitoring Parameters:**
- Lipids, liver function, hematocrit (testosterone)
- Prolactin, estradiol, testosterone levels
- Bone density (especially if puberty suppressed)
- Cardiovascular risk factors

**Surgical Interventions:**

**Chest Surgery:**
- Mastectomy with chest masculinization for trans men
- Breast augmentation for trans women
- Typically requires 12+ months hormones for trans women

**Genital Surgery:**
- Vaginoplasty (penile inversion technique most common)
- Phalloplasty or metoidioplasty for trans men
- Hysterectomy/oophorectomy as appropriate
- Requires 12+ months hormones and letters from mental health providers

**Evidence Base:**

**Mental Health Outcomes:**
Meta-analyses and longitudinal studies demonstrate:
- Significant reduction in depression and anxiety post-treatment
- 50-70% reduction in suichorisk
- Improved body image and self-esteem
- Better social and occupational functioning

**Long-term Studies:**
- Dutch cohort: sustained improvements 10+ years post-transition
- Swedish study: improved quality of life, though some health disparities persist
- Recent studies address previous methodological limitations

**Regret and Detransition:**
- Regret rates consistently low (<1-2%) in recent studies
- Most dissatisfaction relates to surgical outcomes, not identity
- Detransition is rare and often due to external pressures rather than identity change

**Ethical Considerations:**
- Autonomy and informed consent
- Balancing access with appropriate assessment
- Fertility preservation counseling
- Intersectional considerations (race, class, disability)`,
      keyTerms: [
        { term: 'gender dysphoria', definition: 'Diagnostic category describing distress from incongruence between gender identity and assigned sex' },
        { term: 'biopsychosocial model', definition: 'Framework integrating biological, psychological, and social factors in healthcare' },
        { term: 'GnRH agonist', definition: 'Gonadotropin-releasing hormone agonist that suppresses puberty' },
        { term: 'metoidioplasty', definition: 'Surgical procedure creating a neophallus from testosterone-enlarged clitoris' },
        { term: 'phalloplasty', definition: 'Surgical construction of a penis using tissue from donor sites' },
        { term: 'vaginoplasty', definition: 'Surgical creation of a vagina, typically using penile and scrotal tissue' }
      ]
    },
    4: {
      level: 4,
      summary: 'Gender-affirming care represents evidence-based, medically necessary treatment for gender dysphoria with well-established efficacy in improving mental health, quality of life, and overall functioning.',
      explanation: `Gender-affirming care comprises a comprehensive spectrum of interventions for transgender and gender diverse individuals experiencing gender dysphoria. This care is supported by robust evidence and endorsed by major medical and mental health organizations worldwide.

**Diagnostic Framework:**

**Gender Dysphoria (DSM-5):**
- Marked incongruence between experienced/expressed gender and assigned sex
- Duration of at least 6 months
- Clinically significant distress or impairment
- Excludes body image dissatisfaction unrelated to gender

**ICD-11 Classification:**
- "Gender incongruence" moved from mental health to sexual health chapter
- Recognizes this as a condition requiring healthcare, not inherently pathological
- Reduces stigma while maintaining access to care

**Clinical Pathways:**

**Assessment Protocols:**
- Multidisciplinary evaluation (medicine, mental health, social work)
- Assessment of gender identity development and persistence
- Evaluation of mental health comorbidities (depression, anxiety, trauma)
- Social support assessment including family, housing, employment
- Informed consent capacity evaluation

**Treatment Planning:**
- Patient-centered goal setting
- Staged interventions based on developmental stage
- Fertility preservation counseling when appropriate
- Realistic expectation setting regarding outcomes and timelines

**Pediatric and Adolescent Care:**

**Gender-Affirming Care for Youth:**
- Pre-pubertal: social transition, mental health support, family therapy
- Pubertal suppression: GnRH agonists fully reversible, provides time for identity consolidation
- Cross-sex hormones: typically initiated around age 16 for persistent dysphoria
- Surgical interventions: generally deferred until adulthood, except chest surgery in some older adolescents

**Evidence for Youth Interventions:**
- Dutch studies: improved psychological functioning with pubertal suppression
- Recent longitudinal data: gender-affirming care associated with reduced suicidality
- TORDA study (Netherlands): long-term positive outcomes
- Methodological considerations: selection bias, attrition, comparison groups

**Hormone Therapy Management:**

**Feminizing Protocol:**
- Estrogen: target estradiol 100-200 pg/mL
- Anti-androgen options with monitoring for side effects
- Breast development expected (Tanner stages 2-5)
- Fertility generally compromised but not guaranteed eliminated

**Masculinizing Protocol:**
- Testosterone: target mid-normal male range
- Cessation of menses typically 3-6 months
- Fertility may be preserved with egg freezing prior to treatment
- Voice changes permanent; other effects partially reversible if stopped

**Surgical Considerations:**

**Eligibility Criteria:**
- Persistent gender dysphoria
- Capacity to provide informed consent
- Medical and mental health stability
- Social support for recovery
- 12+ months hormones for most procedures (WPATH criteria)

**Outcomes Research:**
- Satisfaction rates high (>90%) for most procedures
- Complication rates comparable to other reconstructive surgeries
- Phalloplasty has higher complication rates but improving with technique advances
- Impact on sexual function variable and individual

**Long-term Health Surveillance:**

**Cardiovascular:**
- Testosterone associated with increased hematocrit, potential CV risk
- Estrogen risk profile depends on formulation and patient factors
- Standard cardiovascular risk factor management

**Cancer Screening:**
- Screen based on organs present regardless of gender identity
- Breast tissue requires screening (mammography, MRI)
- Prostate screening for retained prostate tissue
- Cervical screening for retained cervix

**Bone Health:**
- Monitor bone density, especially with pubertal suppression
- Ensure adequate calcium and vitamin D
- Weight-bearing exercise recommendations

**Mental Health Integration:**
- Ongoing assessment for mood disorders
- Suicide risk monitoring, especially during transition phases
- Support groups and community connection
- Addressing minority stress and discrimination experiences`,
      keyTerms: [
        { term: 'ICD-11', definition: 'International Classification of Diseases, 11th Revision' },
        { term: 'DSM-5', definition: 'Diagnostic and Statistical Manual of Mental Disorders, 5th Edition' },
        { term: 'informed consent', definition: 'Process ensuring patients understand and voluntarily accept treatment' },
        { term: 'multidisciplinary care', definition: 'Coordinated care involving multiple healthcare specialties' },
        { term: 'social transition', definition: 'Living in one\'s affirmed gender without medical interventions' }
      ],
      clinicalNotes: `**Clinical Practice Guidelines:**

**Initial Assessment:**
- Comprehensive history including gender development
- Mental health screening (PHQ-9, GAD-7, suicide risk)
- Social history: support system, housing, employment, legal status
- Medical history: contraindications, cancer risk, cardiovascular risk
- Physical exam: baseline documentation, organ inventory

**Ongoing Management:**
- Regular follow-up every 3-6 months initially, then annually
- Laboratory monitoring per protocol
- Assessment of treatment effects and satisfaction
- Mental health support and resource connection

**Documentation:**
- Record chosen name and pronouns prominently
- Document organ inventory for screening reminders
- Note hormone regimen and monitoring results
- Maintain sensitivity to privacy concerns

**Referral Coordination:**
- Mental health providers with transgender expertise
- Endocrinology for complex cases
- Surgical referrals when appropriate
- Fertility preservation services
- Support groups and community resources

**Special Considerations:**
- Non-binary patients may desire partial transition
- Intersectional needs (race, disability, socioeconomic status)
- Healthcare avoidance due to past discrimination
- Insurance navigation and prior authorization support`
    },
    5: {
      level: 5,
      summary: 'Gender-affirming care represents evidence-based, medically necessary healthcare for gender dysphoria with established efficacy, supported by international guidelines and requiring specialized clinical competencies.',
      explanation: `Gender-affirming care constitutes a specialized domain of healthcare requiring advanced clinical knowledge, interdisciplinary collaboration, and patient-centered approaches. Current evidence supports the medical necessity and efficacy of these interventions for appropriately selected patients.

**Evidence Synthesis:**

**Systematic Reviews and Meta-Analyses:**
Recent comprehensive reviews (Cornell University, 2017; What We Know Project) examining over 50 studies demonstrate:
- Robust positive effects of hormone therapy on psychological functioning
- Significant reductions in suicidality following gender-affirming interventions
- Improvements in quality of life and body image
- High satisfaction rates with surgical interventions

**Methodological Advances:**
Contemporary research addresses limitations of earlier studies through:
- Longitudinal cohort designs with adequate follow-up periods
- Validated outcome measures specific to transgender populations
- Control for confounding variables (social support, baseline mental health)
- Mixed-methods approaches capturing qualitative experiences

**Clinical Guidelines:**

**WPATH Standards of Care Version 8:**
Current standards emphasize:
- Patient autonomy and informed consent
- Individualized care without rigid requirements
- Mental health support but not gatekeeping
- Age-appropriate interventions based on developmental stage
- Global applicability with cultural sensitivity

**Endocrine Society Guidelines:**
- Evidence-based hormone protocols with monitoring parameters
- Pediatric considerations including pubertal suppression
- Long-term health surveillance recommendations
- Fertility preservation counseling requirements

**Specialized Clinical Competencies:**

**Medical Management:**
- Advanced hormone therapy protocols for complex cases
- Management of drug interactions and comorbidities
- Perioperative management for surgical patients
- Long-term health maintenance and cancer screening

**Mental Health Integration:**
- Differential diagnosis of gender dysphoria from other conditions
- Treatment of comorbid mental health conditions
- Family therapy and support
- Letters of support for surgical interventions

**Surgical Care:**
- Pre-operative optimization and hormone management
- Post-operative care and complication management
- Revision surgery considerations
- Long-term functional outcomes assessment

**Controversies and Challenges:**

**Rapid-Onset Gender Dysphoria (ROGD):**
- Proposed subtype describing adolescent females with sudden onset dysphoria
- Controversial and not recognized in major guidelines
- Research methodological criticisms (selection bias, parent-report)
- Clinical approach: standard assessment without predetermined conclusions

**Detransition:**
- True regret and detransition rates low (<1-2%)
- Most detransition temporary or due to external pressures
- Importance of thorough assessment and informed consent
- Supportive care for those who detransition

**Legislative Restrictions:**
- Increasing bans on gender-affirming care for youth in some jurisdictions
- Contradiction of medical consensus and evidence
- Impact on access and patient migration for care
- Legal and ethical challenges

**Research Frontiers:**

**Biological Research:**
- Neuroimaging studies of gender identity development
- Genetic and epigenetic factors in gender diversity
- Hormone effects on brain structure and function
- Long-term cardiovascular outcomes

**Health Services Research:**
- Comparative effectiveness of different treatment approaches
- Implementation science for guideline dissemination
- Health equity and access disparities
- Cost-effectiveness analyses

**Patient-Reported Outcomes:**
- Development of transgender-specific quality of life measures
- Patient-centered outcome prioritization
- Long-term follow-up studies
- Qualitative research on lived experiences

**Intersectional Considerations:**

**Health Equity:**
- Disparities in access by race, ethnicity, and socioeconomic status
- Rural and geographic access challenges
- Insurance coverage limitations
- Workforce diversity in gender-affirming care

**Global Health Perspectives:**
- Cultural variations in gender diversity understanding
- Access challenges in low-resource settings
- Human rights frameworks supporting care access
- Decolonizing approaches to gender-affirming care

**Future Directions:**
- Refinement of hormone protocols with precision medicine approaches
- Advances in surgical techniques and outcomes
- Integration of digital health technologies
- Policy advocacy for improved access and reduced stigma`,
      keyTerms: [
        { term: 'WPATH', definition: 'World Professional Association for Transgender Health' },
        { term: 'informed consent model', definition: 'Approach emphasizing patient autonomy with information provision rather than gatekeeping' },
        { term: 'gatekeeping', definition: 'Historical model requiring extensive mental health assessment before medical care' },
        { term: 'rapid-onset gender dysphoria', definition: 'Controversial proposed subtype of gender dysphoria with sudden adolescent onset' },
        { term: 'patient-reported outcomes', definition: 'Health outcomes reported directly by patients without interpretation' },
        { term: 'precision medicine', definition: 'Approaches tailoring treatment based on individual variability' }
      ],
      clinicalNotes: `**Advanced Clinical Practice:**

**Complex Hormone Management:**
- Adjusting protocols for patients with comorbidities (liver disease, clotting disorders)
- Managing drug interactions with HIV medications or other treatments
- Addressing suboptimal response to standard regimens
- Coordinating care with specialists (endocrinology, hematology)

**Surgical Coordination:**
- Pre-operative risk stratification and optimization
- Hormone management around surgery (timing adjustments, VTE prophylaxis)
- Post-operative complication recognition and management
- Long-term follow-up for surgical outcomes

**Mental Health Integration:**
- Distinguishing gender dysphoria from body dysmorphia or eating disorders
- Managing severe mental illness in the context of gender transition
- Addressing substance use disorders concurrently with transition
- Crisis intervention and suicide prevention

**Family and Relational Care:**
- Family therapy for accepting and non-accepting families
- Couples counseling through transition
- Parenting considerations and fertility counseling
- Support for partners and spouses

**Non-Binary and Gender Diverse Populations:**
- Individualized partial transition goals
- Non-binary hormone dosing strategies
- Surgical options beyond binary frameworks
- Documentation and legal considerations

**Research and Scholarship:**
- Contributing to evidence base through outcome tracking
- Participating in multicenter research studies
- Publishing case series and clinical innovations
- Mentoring next generation of providers

**Advocacy and Leadership:**
- Institutional policy development for inclusive care
- Insurance advocacy and prior authorization support
- Community education and destigmatization
- Professional organization involvement`
    }
  },
  media: [],
  citations: [
    {
      id: 'wpath-soc8',
      type: 'textbook',
      title: 'Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, Version 8',
      source: 'World Professional Association for Transgender Health'
    },
    {
      id: 'endocrine-guidelines',
      type: 'article',
      title: 'Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline',
      authors: ['Hembree WC', 'Cohen-Kettenis PT', 'Gooren L', 'et al.'],
      source: 'Journal of Clinical Endocrinology and Metabolism'
    }
  ],
  crossReferences: [
    { targetId: 'hormone-therapy', targetType: 'concept', relationship: 'child', label: 'Hormone Therapy' },
    { targetId: 'surgical-options', targetType: 'concept', relationship: 'child', label: 'Surgical Options' },
    { targetId: 'transgender-youth', targetType: 'concept', relationship: 'related', label: 'Transgender Youth' }
  ],
  tags: {
    systems: ['endocrine', 'reproductive'],
    topics: ['lgbtq-health', 'transgender-health', 'endocrinology'],
    keywords: ['gender-affirming care', 'transgender', 'gender dysphoria', 'hormone therapy', 'transition']
  },
  createdAt: new Date().toISOString(),
  updatedAt: new Date().toISOString(),
  version: 1,
  status: 'published'
};

export default genderAffirmingCare;
